Holen Sie sich die Stockscreener-App
44.65
1.25%
0.55
Handel nachbörslich:
44.59
-0.06
-0.13%
Schlusskurs vom Vortag:
$44.10
Offen:
$44.31
24-Stunden-Volumen:
3.54M
Relative Volume:
0.87
Marktkapitalisierung:
$19.08B
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$1.30B
KGV:
25.53
EPS:
1.7487
Netto-Cashflow:
$1.05B
1W Leistung:
+7.13%
1M Leistung:
+9.84%
6M Leistung:
+20.29%
1J Leistung:
+42.20%
1-Tages-Spanne:
$43.95
$44.92
1-Wochen-Bereich:
$41.46
$44.92
52-Wochen-Spanne:
$29.66
$44.92
Royalty Pharma Plc Stock (RPRX) Company Profile
Firmenname
Royalty Pharma Plc
Sektor
Branche
Telefon
(212) 883-0200
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
44.65 | 18.84B | 2.35B | 1.30B | 1.05B | 1.7487 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.92 | 116.41B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.51 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
811.45 | 50.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.76B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
353.92 | 38.40B | 4.98B | 69.60M | 525.67M | 0.5198 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | UBS | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Buy |
| 2025-05-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-06-03 | Herabstufung | UBS | Buy → Neutral |
| 2022-06-14 | Fortgesetzt | UBS | Buy |
| 2022-05-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-30 | Eingeleitet | Tigress Financial | Buy |
| 2020-11-09 | Hochstufung | UBS | Neutral → Buy |
| 2020-07-14 | Eingeleitet | Evercore ISI | In-line |
| 2020-07-13 | Eingeleitet | BofA Securities | Buy |
| 2020-07-13 | Eingeleitet | Citigroup | Neutral |
| 2020-07-13 | Eingeleitet | Cowen | Outperform |
| 2020-07-13 | Eingeleitet | Goldman | Neutral |
| 2020-07-13 | Eingeleitet | JP Morgan | Neutral |
| 2020-07-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Eingeleitet | SunTrust | Buy |
| 2020-07-13 | Eingeleitet | UBS | Neutral |
Alle ansehen
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
Thrivent Financial for Lutherans Trims Stake in Royalty Pharma PLC $RPRX - MarketBeat
Ultragenyx (RARE) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Finviz
Royalty Pharma PLC (NASDAQ:RPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 1-Year HighHere's What Happened - MarketBeat
Royalty Pharma EVP Coyne sells $10.3 million in shares By Investing.com - Investing.com Nigeria
C WorldWide Group Holding A S Raises Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Homestead Advisers Corp Sells 37,000 Shares of Royalty Pharma PLC $RPRX - MarketBeat
(RPRX) Risk Channels and Responsive Allocation - Stock Traders Daily
Royalty Pharma Set for Upcoming Dividend Payment - intellectia.ai
Royalty Pharma (NASDAQ:RPRX) CFO Sells $4,924,629.36 in Stock - MarketBeat
Terrance Coyne Sells 108,424 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
Terrance Coyne Sells 20,163 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy? - Finviz
AE Wealth Management LLC Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
The Best Biotech Stocks to Buy - morningstar.com
Urist Marshall, royalty pharma EVP, sells $821,810 in shares By Investing.com - Investing.com South Africa
Urist Marshall, royalty pharma EVP, sells $821,810 in shares - Investing.com
Royalty Pharma (RPRX) Stock Analysis: Analysts See 15% Upside Potential - DirectorsTalk Interviews
Marshall Urist Sells 20,000 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys 31,045 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Strs Ohio Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma (RPRX) Still Attractive After A 35% One Year Share Price Gain - Yahoo Finance
Royalty Pharma stock hits 52-week high at $41.71 By Investing.com - Investing.com India
Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year HighShould You Buy? - MarketBeat
Royalty Pharma stock hits 52-week high at $41.71 - Investing.com
Royalty Pharma Shares Rise After UBS Upgrade - marketscreener.com
UBS Upgrades Royalty Pharma to Buy From Neutral, Adjusts Price Target to $49 From $38 - marketscreener.com
Ruffer LLP Decreases Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Assessing Royalty Pharma (RPRX) Valuation After Teva Autoimmune Funding Partnership Attracts Fresh Attention - Sahm
Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 20,000 Shares of Stock - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Royalty Pharma to buy royalty interest in Amgen’s Imdelltra for up to $950M - MSN
Mitsubishi UFJ Trust & Banking Corp Sells 198,889 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Cullen Frost Bankers Inc. Raises Position in Royalty Pharma PLC $RPRX - MarketBeat
(RPRX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Jim Cramer on Royalty Pharma: "It's a Terrific Company" - Finviz
84,741 Shares in Royalty Pharma PLC $RPRX Bought by Oxbow Advisors LLC - MarketBeat
Jim Cramer on Royalty Pharma: “It’s a Terrific Company” - Insider Monkey
Jim Cramer Shared His Takes on These 16 Stocks - Insider Monkey
Baillie Gifford & Co. Trims Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma EVP Coyne sells shares worth $2.7 million By Investing.com - Investing.com Nigeria
Royalty Pharma EVP Coyne sells shares worth $2.7 million - Investing.com
Terrance Coyne Sells 69,582 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
Smart Money: Is UAMY stock a buy or sellGDP Growth & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Royalty Pharma's (NASDAQ:RPRX) Upcoming Dividend Will Be Larger Than Last Year's - simplywall.st
How Investors May Respond To Royalty Pharma (RPRX) Dividend Hike Amid Insider Sales And Results Countdown - Yahoo Finance
Royalty Pharma (RPRX) Valuation Check After Recent Share Pullback And Strong 1 Year Return - Yahoo Finance
Patient Capital Management LLC Boosts Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma Dividend Hike Highlights Income Appeal And Undervaluation - Sahm
Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $790,400.00 in Stock - MarketBeat
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
5.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):